| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/11/2009 | US20090149420 Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/11/2009 | US20090149410 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090148542 Composition comprising an extract of tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 06/11/2009 | US20090148539 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090148507 Chimeric polypeptides containing chemokine domains |
| 06/11/2009 | US20090148499 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 06/11/2009 | US20090148476 Chemodenervating pharmaceutical as anti-inflammatory agent |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148444 Pharmaceutical composition for treating immune diseases |
| 06/11/2009 | CA2708532A1 Anti-nr10 antibody and use thereof |
| 06/11/2009 | CA2707666A1 Systems and methods for delivery of materials |
| 06/11/2009 | CA2707555A1 Piperazines as anti-obesity agents |
| 06/11/2009 | CA2706883A1 Methods of treating copd |
| 06/11/2009 | CA2704266A1 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
| 06/10/2009 | EP2067784A2 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents |
| 06/10/2009 | EP2067777A1 Oxepin derivative |
| 06/10/2009 | EP2067776A1 Piperidine compounds and pharmaceutical compositions containing them |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2066800A2 Aryl amino acid derivatives as inhibitors of lta4h (leukotriene a4 hydrolase) for treating inflammation |
| 06/10/2009 | EP2066685A2 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists |
| 06/10/2009 | EP2066669A1 Adenosine derivatives as a2a receptor agonists |
| 06/10/2009 | EP2066663A1 Heterocyclic fxr binding compounds |
| 06/10/2009 | EP2066662A2 Serine hydrolase inhibitors |
| 06/10/2009 | EP2066653A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents |
| 06/10/2009 | EP2066324A2 Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 06/10/2009 | EP2066316A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 06/10/2009 | EP1713805B1 Kinase inhibitors |
| 06/10/2009 | EP1601673B1 Fused heterocycles and uses thereof |
| 06/10/2009 | EP1385490B1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins |
| 06/10/2009 | EP1135122B1 Use of amtolmetin guacyl as for the treatment of intestinal inflammations |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496607C Combination of a NSAID and a PDE-4 inhibitor |
| 06/10/2009 | CN100496596C Improved Chinese medicinal paste for arthralgia and its preparation |
| 06/10/2009 | CN100496526C Preparation of soft capsule of Chinese traditional medicine for treating rheumatism and preparation method |
| 06/10/2009 | CN100496493C 2-amino-4, 5-trisubstituted thiazolyl derivatives |
| 06/10/2009 | CN100496472C Topical compositions and methods for treating pain |
| 06/09/2009 | US7544859 for introducing DNA into organisms which produce large amounts of oils; genetic engineering; for animal feed, foods, cosmetics and pharmaceuticals; kits |
| 06/09/2009 | US7544853 C1 inhibitor with short half-life transient treatment |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 06/09/2009 | US7544716 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease |
| 06/09/2009 | US7544711 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
| 06/09/2009 | US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 06/09/2009 | US7544694 Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists |
| 06/09/2009 | US7544691 Guanidine derivatives |
| 06/09/2009 | US7544684 Hydrazono-malonitriles |
| 06/09/2009 | US7544669 Polynucleotide therapy |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544480 drug screening an antagonist which inhibits hydroxylation of hypoxia inducible factor or an agonist which promotes hydroxylation of hypoxia inducible factor; hydroxylation of asparagine; antitumor agent; use for radiotherapy or chemotherapy |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | CA2444814C Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
| 06/09/2009 | CA2410706C Composition and applicator for topical substance delivery |
| 06/09/2009 | CA2394232C Dual-release compositions of a cyclooxygenase-2-inhibitor |
| 06/09/2009 | CA2352796C Milling process for the production of finely milled medicinal substances |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009070485A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES |
| 06/04/2009 | WO2009070378A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | WO2009069764A1 Opioid analgesic agent |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069643A1 Solid dispersion comprising 3-[5-[4-(cyclopentyloxy)- 2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof, or composition comprising the solid dispersion |
| 06/04/2009 | WO2009068967A1 Processes for preparing a substituted gamma-amino acid |
| 06/04/2009 | WO2009068649A2 Antigen-binding constructs |
| 06/04/2009 | WO2009068512A1 2 -amino-pyrimidine derivatives as histamine h4 antagonists |
| 06/04/2009 | WO2009068482A1 Amino triazoles as pi3k inhibitors |
| 06/04/2009 | WO2009068177A1 DERIVATIVES OF 4-(2-AMINO-1 -HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 06/04/2009 | WO2009067755A1 Therapeutic targets and medicaments involving p230/golgin-245 |
| 06/04/2009 | WO2009040314A3 Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2 |
| 06/04/2009 | WO2009022346A3 Phenyl carbamates for treating gastrointestinal inflammation |
| 06/04/2009 | WO2008134814A4 A method for treating inflammation and controlled-release material capable of providing same |
| 06/04/2009 | US20090143462 Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same |
| 06/04/2009 | US20090143455 Pyrazoles Useful in the Treatment of Inflammation |
| 06/04/2009 | US20090143442 Thiazolidinedione analogues |
| 06/04/2009 | US20090143428 Quinoline Derivatives 057 |
| 06/04/2009 | US20090143421 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 06/04/2009 | US20090143420 2-benzoylimidazopyridine derivatives, preparation and therapeutic use thereof |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143382 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 06/04/2009 | US20090143375 Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents |
| 06/04/2009 | US20090143361 Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 |
| 06/04/2009 | US20090143358 Inhibitors of ion channels |
| 06/04/2009 | US20090143349 Steroid tetrol solid state forms |
| 06/04/2009 | US20090143336 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 06/04/2009 | US20090143319 Transcription factor decoy |
| 06/04/2009 | US20090143300 Treatment of sepsis and septic shock using ghrelin and growth hormone |
| 06/04/2009 | US20090143281 Thrombomodulin analogs for use in recovery of spinal cord injury |
| 06/04/2009 | US20090143276 Trimeric IL-1Ra |
| 06/04/2009 | US20090142831 Placental stem cells |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | US20090142428 Extracts from the Bark of Corynanthe Species and Use Thereof as Well as Medicaments, Dietetic Food Products and Pharmaceutical Preparations Containing Said Extracts |
| 06/04/2009 | US20090142419 Anti-inflammatory extract and agent and method for the production thereof |
| 06/04/2009 | US20090142400 Analgesic coated medical product |
| 06/04/2009 | US20090142375 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses madiated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 06/04/2009 | US20090142339 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 06/04/2009 | US20090142330 Use of inactive-plasmin to treat chronic inflammatory disease and tumors |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142301 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |